Faron Pharmaceuticals Oy (FARN) Sets New 12-Month High at $870.00

Shares of Faron Pharmaceuticals Oy (LON:FARN) hit a new 52-week high on Wednesday . The stock traded as high as GBX 870 ($11.24) and last traded at GBX 870 ($11.24), with a volume of 4,000 shares. The stock had previously closed at GBX 800 ($10.33).

Separately, Panmure Gordon restated a “buy” rating and set a GBX 723 ($9.34) price objective on shares of Faron Pharmaceuticals Oy in a research report on Wednesday, September 6th.

The firm’s market capitalization is GBX 237.42 million. The company’s 50 day moving average is GBX 705.90 and its 200-day moving average is GBX 673.12.

In related news, insider Jonathan Knowles purchased 63,000 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was acquired at an average price of GBX 725 ($9.36) per share, with a total value of £456,750 ($589,887.64).

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://stocknewstimes.com/2017/09/13/faron-pharmaceuticals-oy-farn-sets-new-12-month-high-at-870-00.html.

Faron Pharmaceuticals Oy Company Profile

Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply